Clinical Transplantation

Article	Citations
Early effects of first‐line treatment with anti‐interleukin‐6 receptor antibody tocilizumab for chronic active antibody‐mediated rejection in kidney transplantation	51
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States	44
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications	38
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcare	37
Pig kidney xenotransplantation: Progress toward clinical trials	37
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review	35
Financial impact of delayed graft function in kidney transplantation	34
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19	32
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience	32
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe	30
Convalescent plasma therapy: Helpful treatment of COVID‐19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications	30
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study	29
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database	28
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant	28
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine	27
Enhanced recovery after surgery programs improve short‐term outcomes after liver transplantation–A systematic review and meta‐analysis	26
A short overview on mycophenolic acid pharmacology and pharmacokinetics	25
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an	25
Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States	24
Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: Experience at large transplant center in New York City	24
Attenuated early inflammatory response in solid organ recipients with COVID‐19	23
Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost	23
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors	23
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies	22
Transplant outcomes using kidneys from high KDPI acute kidney injury donors	21

Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come	21
To kidney or not to kidney: Applying lessons learned from the simultaneous liver‐kidney transplant policy to simultaneous heart‐kidney transplantation	21
Protocolized exercise improves frailty parameters and lower extremity impairment: A promising prehabilitation strategy for kidney transplant candidates	20
Pre‐transplant short physical performance battery: Response to pre‐habilitation and relationship to pre‐ and early post–lung‐transplant outcomes	20
Tocilizumab use in Kidney Transplant Patients with COVID‐19	19
Using race to estimate glomerular filtration and its impact in kidney transplantation	19
The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy	19
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations	18
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment	18
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis	18
Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea	18
Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes	18
Telehealth in outpatient management of kidney transplant recipients during COVID‐19 pandemic in New York	17
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations	17
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center	17
Prognostic value of the donor‐derived cell‐free DNA assay in acute renal rejection therapy: A prospective cohort study	17
Pediatric lung transplantation as standard of care	16
Abdominal wall complications after kidney transplantation: A clinical review	16
Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing	15
The changing landscape of pediatric lung transplantation	15
Wait expectations: The impact of delisting as an outcome from the kidney transplant waitlist	15
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy	15
Belatacept, kidney transplantation and COVID‐19: Successful management of the first reported case within the United Kingdom	15
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations	15
Lung transplantation for the treatment of irreversible acute respiratory distress syndrome	15
The type of SARS‐CoV‐2 vaccine influences serological response in kidney transplant recipients	14
Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)	14
Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system	14
Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis	14
The impact of the SARS‐CoV‐2 pandemic and COVID‐19 on lung transplantation in the UK: Lessons learned from the first wave	14
Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry	14
Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients	14
Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart	14
Gender differences in heart transplantation: Twenty‐five year trends in the nationwide Spanish heart transplant registry	14
Normothermic with or without hypothermic oxygenated perfusion for DCD before liver transplantation: European multicentric experience	13
Renal transplantation during the SARS‐CoV‐2 pandemic in the UK: Experience from a large‐volume center	13
Acute kidney injury post‐heart transplant: An analysis of peri‐operative risk factors	13
What is the optimal anesthetic monitoring regarding immediate and short‐term outcomes after liver transplantation?—A systematic review of the literature and expert panel recommendations	13
Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality	13
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial	13
Kidney allograft rejection: Diagnosis and treatment practices in USA‐ A UNOS survey	13
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients	13
Meta‐analysis and systematic review: Prevalence, graft failure, mortality, and post‐operative thrombosis in liver transplant recipients with pre‐operative portal vein thrombosis	13
Exploring the motives of Israeli Jews who were living kidney donors to strangers	13
A proposed strategy for management of immunosuppression in heart transplant patients with COVID‐19	13
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies	13
Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience	13
Long‐term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism	13
Mobile health technology to improve emergent frailty after lung transplantation	12
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia	12

Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation	12
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump	12
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation	12
A Step toward Standardization: Results of two National Surveys of Best Practices in Donation after Circulatory Death Liver Recovery and Recommendations from The American Society of Transplant Surgeons	12
Hyperammonemia syndrome associated with Ureaplasma spp. Infections in immunocompromised patients and transplant recipients: A systematic review and meta‐analysis	12
Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs	12
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction	12
Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation	12
eHealth literacy and web‐based patient portal usage among kidney and liver transplant recipients	12
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendatio	12
Exercise interventions in solid organ transplant candidates: A systematic review	12
A single‐center long‐term experience with marginal donor utilization for heart transplantation	12
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia	11
ProtekDuo as a bridge to lung transplant and heart‐lung transplant	11
Predicting harmful alcohol relapse after liver transplant: The HALT score	11
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review	11
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations	11
Transplantation of kidneys after normothermic perfusion: A single center experience	11
Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS‐CoV‐2 pandemic in New York City: A single‐center experience	11
Polygenic risk score of non‐melanoma skin cancer predicts post‐transplant skin cancer across multiple organ types	11
The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations	11
A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic	11
SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients	11
Model for early allograft function is predictive of early graft loss in donation after circulatory death liver transplantation	11
Variations in deceased donor kidney procurement biopsy practice patterns: A survey of U.S. organ procurement organizations	11
Left‐digit bias and deceased donor kidney utilization	11
Optimal anesthetic conduct regarding immediate and short‐term outcomes after liver transplantation – Systematic review of the literature and expert panel recommendations	11
Impact of donor smoking history on post heart transplant outcomes: A propensity‐matched analysis of ISHLT registry	10
Care of international living kidney donor candidates in the United States: A survey of contemporary experience, practice, and challenges	10
The role of acute in‐patient rehabilitation on short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	10
Early persistent hyperparathyroidism post‐renal transplantation as a predictor of worse graft function and mortality after transplantation	10
Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID‐19	10
The role of early extubation on short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert recommendations	10
Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables	10
National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation	10
Quick preparation of ABO‐incompatible living donor liver transplantation for acute liver failure	10
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin	10
Decreased frequency of transplantation and lower post‐transplant survival free of re‐transplantation in LVAD patients with the new heart transplant allocation system	10
Sex and gender disparity in kidney transplantation: Historical and future perspectives	10
Early changes in IL‐21, IL‐22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: A proof of concept study	10
Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature	10
Textbook surgical outcome in lung transplantation: Analysis of a US national registry	10
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation	10
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization	10
Strict selection criteria in uncontrolled donation after circulatory death provide excellent long‐term kidney graft survival	10
Incidence and risk factors of primary non‐function after liver transplantation using grafts from uncontrolled donors after circulatory death	10
Post‐transplant survival in adult congenital heart disease patients as compared to dilated and ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT registry	10
Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: A retrospective, multicentric study	10
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases	10
Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct‐acting antiviral initiation	9
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy	9
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol‐related liver disease	9
The impact of marijuana use on liver transplant recipients: A 900 patient single center experience	9
Long‐term outcomes of Roux‐en‐Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center's experience	9
Optimal management of perioperative analgesia regarding immediate and short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert panel recommendations	9
Anesthetic management of lung transplantation: Results from a multicenter, cross‐sectional survey by the society for advancement of transplant anesthesia	9
Predictive score for immediate extubation after liver transplantation	9
Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl	9
Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?	9
Acute and chronic kidney disease after pediatric liver transplantation: An underestimated problem	9
Increased frequency of heart transplantation, shortened waitlist time and preserved post‐transplant survival in adults with congenital heart disease, on the new heart transplant allocation system	9
Molecular assessment of antibody‐mediated rejection in human pancreas allograft biopsies	9
Lung allocation for transplant: The European perspective	9
Risk of COVID‐19 in young kidney transplant recipients. Results from a single‐center observational study	9
Optimal surgical workup to ensure safe recovery of the donor after living liver donation – A systematic review of the literature and expert panel recommendations	9
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant‐related risk factors and current state of prophylaxis	9
Which cava anastomotic techniques are optimal regarding immediate and short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations	9
Anti‐Hla donor‐specific antibody monitoring in pancreas transplantation: Role of protocol biopsies	9
The COVID‐19 pandemic: A community approach	9
Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients	9
Blood product transfusion and lung transplant outcomes: A systematic review	8
Impact of induction therapy on outcomes after heart transplantation	8
The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations	8
Impact of diabetes mellitus on clinical outcomes after heart transplantation	8
Impact of COVID‐19 pandemic on the size of US transplant waiting lists	8
An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients	8
Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply	8
Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection	8
Ethical considerations regarding COVID‐19 vaccination for transplant candidates and recipients	8
Implementation of a mobile team to provide normothermic regional perfusion in controlled donation after circulatory death: Pilot study and first results	8

Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients	8
Long‐term outcomes in kidney transplant recipients with end‐stage kidney disease due to anti‐glomerular basement membrane disease	8
Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation	8
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and	8
Geographic disparities in heart transplantation persist under the new allocation policy	8
Outcomes of kidney donors with pre‐ and post‐donation kidney stones	8
Physician and patient acceptance of policies to reduce kidney discard	8
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant	8
Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome	8
Survival and renal function after liver transplantation alone in patients meeting the new United Network for Organ Sharing simultaneous liver‐kidney criteria	8
Video education to facilitate patient outreach about living kidney donation: A proof of concept	8
Podocyte density is reduced in kidney allografts with high‐risk APOL1 genotypes at transplantation	8
Public education materials about Vascular Composite Allotransplantation and donation in the United States: Current scope and limitations	8
Impact of warm ischemia time on outcomes for kidneys donated after cardiac death Post‐KAS	8
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy	8
Current status and further potential of lung donation after circulatory death	8
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study	8
Clinical outcome of kidney transplantation after bariatric surgery: A single‐center, retrospective cohort study	8
Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression	8
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results	8
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients	8
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system	8
Multimodal opioid‐sparing pain management after lung transplantation and the impact of liposomal bupivacaine intercostal nerve block	8
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression	8
Transcriptional analysis identifies potential novel biomarkers associated with successful ex‐vivo perfusion of human donor lungs	7
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients	7
Torquetenovirus viral load is associated with anti‐spike antibody response in SARS‐CoV‐2 mRNA BNT162b2 vaccinated kidney transplant patients	7
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States	7
Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound	7
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation	7
Donor‐derived cell‐free DNA in a heart transplant patient with COVID‐19	7
Plasma mycophenolic acid concentration and the clinical outcome after lung transplantation	7
Cognitive impairment burden in older and younger adults across the kidney transplant care continuum	7
Combination of pancreas volume and HbA1c level predicts islet yield in patients undergoing total pancreatectomy and islet autotransplantation	7
Gastric peroral endoscopic myotomy (GPOEM) for severe gastroparesis after lung transplantation: A promising minimally invasive option	7
When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series	7
Does prolonged cold ischemia affect outcomes in donation after cardiac death donor kidney transplants?	7
Impact of body mass index and recipient age on baseline donor‐derived cell free DNA (dd‐cfDNA) in kidney transplant recipients	7
Outcomes among CMV‐mismatched and highly sensitized kidney transplants recipients who develop neutropenia	7
BK virus nephropathy in non‐renal solid organ transplant recipients: Are we looking hard enough?	7
The Molecular Microscope (MMDXR) interpretation of thoracic and abdominal allograft biopsies: Putting things in perspective for the clinician	7
User‐centered design features for digital health applications to support physical activity behaviors in solid organ transplant recipients: A qualitative study	7
Bioavailability of once‐daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study	7
Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes	7
A comparison of cardiopulmonary bypass versus extracorporeal membrane oxygenation: Does intraoperative circulatory support strategy affect outcomes in pediatric lung transplantation?	7
Marijuana use among adult liver transplant candidates and recipients	7
Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression	7
NSAID prescriptions in kidney transplant recipients	7
ABO‐incompatible living kidney transplantation	7
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors	7
The effects of donor‐specific antibody characteristics on cardiac allograft vasculopathy	7
Race does not predict pancreas graft failure after pancreas transplantation in the modern era	7
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients	7
Risk factors for portal vein stenosis in pediatric liver transplantation	7
One‐year immunologic outcomes of lung transplantation utilizing hepatitis C‐viremic donors	7
Perioperative management of living donor liver transplantation: Part 2 – Donors	7
Evaluating resilience as a predictor of outcomes in lung transplant candidates	7
Recipient age and outcomes following simultaneous pancreas‐kidney transplantation in the new millennium: Single‐center experience and review of the literature	7
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients	7
Racial disparities in living donor kidney transplantation in the United States	7
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario	7
Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan	7
Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta‐analysis	7
Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis	7
Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization	7
Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients	7
Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation	7
Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients	7
Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients	7
Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot	7
Presence of any degree of coronary artery disease among liver transplant candidates is associated with increased rate of post‐transplant major adverse cardiac events	7
A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United States	7
In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes	7
Implementation of patient‐reported outcome measures in a heart transplant recipient registry: First step toward a patient‐centered approach	7
The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study	7
Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era	7
Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant recipients	7
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience	6
COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions	6
Association of CMV‐specific T‐cell immunity and risk of CMV infection in lung transplant recipients	6
Post‐transplant lymphoproliferative disorder with cutaneous involvement: A series of four cases	6
Role of a cardio‐renal multi‐disciplinary team meeting in managing cardiovascular risk in patients on kidney transplant waitlists	6
COVID‐19 in heart transplant recipients—A seroprevalence survey	6
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation	6
Use of Continuous Glucose Monitoring for evaluation of hypoglycemia pre‐ and post‐operatively for patients undergoing Total Pancreatectomy with Autologous Islet Cell Transplant	6
The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations	6
Comparing outcomes in right versus left kidney transplantation: A systematic review and meta‐analysis	6
Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study	6
Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States	6
Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients	6
Predictive value of chart‐based frailty evaluation for lung transplant candidates	6
Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant	6
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy	6
Outcome implications of benzodiazepine and opioid co‐prescription in kidney transplant recipients	6
The efficacy of interleukin‐1 antagonist drugs in combination with colchicine in patients with FMF‐AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence	6